AUS
NZ
UK
CA
USA
IND
Highlights
- IBEX reports record Q2 FY2025 revenue of $140.7 million, up 6.1% YoY.
- Net income jumps 52.6% to $9.3 million, reflecting solid profitability.
- HealthTech vertical sees impressive growth of 31.2%, driving overall performance.
IBEX has delivered an outstanding financial performance for Q2 FY2025, ending December 31, 2024, with the company reaching new highs in revenue and profitability. IBEX posted record quarterly revenue of $140.7 million, reflecting a 6.1% growth year-over-year. This achievement underscores the company’s strong market position and its ability to expand across diverse business segments.
The company's net income showed significant growth, increasing 52.6% to reach $9.3 million. This impressive surge in profitability highlights IBEX's effective cost management strategies and its strong revenue generation across its business divisions. Additionally, IBEX reported a notable 15.4% increase in Adjusted EBITDA, which climbed to $16.5 million, with the Adjusted EBITDA margin expanding to 11.8%, up 100 basis points from the same period last year. These results reflect improved operational efficiency and a focus on driving higher margins.
IBEX also reported a 36.3% increase in Adjusted Earnings Per Share (EPS), which rose to $0.59 for Q2 FY2025. The significant jump in EPS reflects the company's success in balancing revenue growth and effective cost control, delivering strong returns for its shareholders.
A key milestone for IBEX was the completion of a $70 million share repurchase from TRGI, which resulted in the elimination of the company's controlled status. This strategic move enhances IBEX’s corporate governance and positions the company for further growth as an independent entity.
Growth for IBEX was driven by solid performances across several key verticals. The HealthTech segment led the charge with an impressive 31.2% growth, reflecting increasing demand for health technology solutions in a rapidly evolving market. The Travel, Transportation, and Logistics segment also saw strong growth, with a 16.7% increase, benefiting from the ongoing recovery and increasing consumer demand in these industries. The Retail & E-commerce segment contributed positively as well, posting a 4.4% growth for the quarter.
However, IBEX faced challenges in its FinTech vertical, which saw a 14.7% decline. This drop highlights the pressures in the FinTech space, driven by market fluctuations and competitive dynamics. Additionally, the company’s net debt position shifted to $13.7 million as of December 31, 2024, a notable change from the net cash position of $61.2 million reported in June 2024. This shift raised concerns about IBEX's financial flexibility. Furthermore, the company posted negative free cash flow of $3.2 million, which could be an area of concern for investors looking for sustained cash generation.
Despite these challenges, IBEX raised its full-year FY2025 guidance, now expecting revenue between $525 million and $535 million and Adjusted EBITDA in the range of $68 million to $69 million. This upward revision underscores IBEX’s confidence in its business outlook and its ability to capitalize on growth opportunities across key segments.
